Archives

  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • 2021-12
  • 2021-11
  • 2021-10
  • 2021-09
  • 2021-08
  • 2021-07
  • 2021-06
  • 2021-05
  • 2021-04
  • 2021-03
  • 2021-02
  • 2021-01
  • 2020-12
  • 2020-11
  • 2020-10
  • 2020-09
  • 2020-08
  • 2020-07
  • 2020-06
  • 2020-05
  • 2020-04
  • 2020-03
  • 2020-02
  • 2020-01
  • 2019-12
  • 2019-11
  • 2019-10
  • 2019-09
  • 2019-08
  • 2019-07
  • 2019-06
  • 2019-05
  • 2019-04
  • 2018-07
  • Butylated hydroxyanisole (BHA): Synthetic Antioxidant for...

    2026-02-19

    Butylated hydroxyanisole (BHA): Synthetic Antioxidant for Oxidative Stress Research

    Executive Summary: Butylated hydroxyanisole (BHA, 2-(tert-butyl)-4-methoxyphenol, CAS 25013-16-5) is a synthetic antioxidant with >98% purity, confirmed by HPLC and NMR analyses (APExBIO product page). BHA acts as a free radical scavenger, effectively inhibiting lipid peroxidation and oxidative degradation in biochemical assays. Its solubility profile (≥34 mg/mL in DMSO/ethanol, insoluble in water) allows broad experimental integration. The compound is extensively used in research on oxidative stress, reactive oxygen species (ROS) detection, apoptosis, and inflammation signaling. APExBIO supplies BHA (SKU C6525) specifically for scientific research, not for diagnostic or medical use (APExBIO).

    Biological Rationale

    BHA is a phenolic antioxidant designed to prevent oxidative damage in biological and chemical systems. Its core structure, 2-(tert-butyl)-4-methoxyphenol, allows for the donation of a hydrogen atom to neutralize free radicals, terminating chain reactions of lipid peroxidation. This property is crucial for protecting cellular membranes and proteins in studies of oxidative stress, a central process in the pathogenesis of cancer, neurodegenerative diseases, and inflammation (Samant et al., 2005). The relevance of synthetic antioxidants like BHA extends to their utility as experimental controls, calibration standards, and pathway modulators in both in vitro and in vivo research models (Related article: BHA in advanced disease models – this article provides updated mechanistic insights compared to earlier reviews).

    Mechanism of Action of Butylated hydroxyanisole (BHA)

    BHA exerts its effects primarily by interrupting free radical chain reactions. The compound's phenolic hydrogen is readily donated to lipid or peroxyl radicals, forming a resonance-stabilized phenoxyl radical, which is less reactive (BHA mechanism review – this article expands on kinetic parameters; here, newer solubility and workflow data are provided). This prevents propagation of oxidative damage in cell membranes and biomolecules. In cell-based systems, BHA has been shown to reduce intracellular ROS, attenuate activation of downstream apoptosis signaling pathways (e.g., caspase-3, Bcl-2 family modulation), and limit inflammatory responses. These mechanisms are validated in diverse assay formats, including fluorescent ROS probes and immunoblotting for oxidative stress markers.

    Evidence & Benchmarks

    • BHA at concentrations ≥10 μM effectively inhibits lipid peroxidation in vitro, as measured by TBARS assay, under aerobic conditions (Samant et al. 2005, DOI).
    • High-purity BHA (≥98%, HPLC/NMR-verified) ensures reproducibility in ROS detection assays and minimizes assay interference (APExBIO documentation).
    • In DMSO and ethanol, BHA achieves solubility of at least 34 mg/mL at 20°C, supporting stock solution preparation for cell-based and enzymatic assays (internal protocol).
    • BHA has been shown to reduce experimental variability in oxidative stress and apoptosis assays compared to less pure commercial alternatives (scenario-driven guidance – this article offers expanded benchmarking data).
    • BHA's antioxidant effect is dose-dependent, with diminished returns above 100 μM in standard cell culture models (Samant et al. 2005, DOI).

    Applications, Limits & Misconceptions

    BHA is used across multiple research domains:

    • Oxidative stress studies: BHA serves as a positive control for ROS suppression and lipid peroxidation inhibition in biochemical and cell-based assays.
    • Apoptosis signaling: BHA modulates key apoptotic pathways by attenuating ROS-mediated caspase activation, allowing researchers to dissect pro- and anti-apoptotic signaling.
    • Inflammation research: By limiting oxidative signaling, BHA indirectly modulates NF-κB and related inflammatory cascades (BHA in inflammation – this article focuses on disease models; the current article details experimental integration and purity data).
    • Cancer and neurodegenerative models: BHA is used to probe oxidative damage and cellular protection mechanisms in models of neurodegeneration and tumorigenesis.

    Common Pitfalls or Misconceptions

    • BHA is not water-soluble: It requires DMSO or ethanol as solvents; improper solubilization can lead to inconsistent assay outcomes.
    • Not for diagnostic or therapeutic use: BHA supplied by APExBIO is for research purposes only, not for clinical or food additive applications.
    • Antioxidant activity is context-dependent: BHA's efficacy may vary with cell type, buffer composition, and assay format; dose optimization is required.
    • Overuse can cause cytotoxicity: Concentrations significantly above 100 μM may induce cellular toxicity, confounding interpretation.
    • Batch purity matters: Lower-purity BHA from non-validated sources can introduce assay artifacts due to contaminant pro-oxidants.

    Workflow Integration & Parameters

    BHA (C6525) is supplied as a crystalline solid by APExBIO, with a stated purity of approximately 98%, and validated by HPLC and NMR. Recommended storage is at -20°C in a dark, dry environment to prevent degradation. BHA is insoluble in water but dissolves at ≥34 mg/mL in DMSO or ethanol at 20°C. Typical working concentrations range from 1–100 μM for in vitro experiments. Stock solutions should be freshly prepared or stored short-term at -20°C to maintain activity. For ROS detection or apoptosis assays, researchers add BHA to cell cultures or biochemical reaction mixtures as a positive control or experimental modulator. Proper solubilization and dilution protocols are critical for assay consistency (Butylated hydroxyanisole (BHA) product details).

    Conclusion & Outlook

    BHA remains a gold-standard synthetic antioxidant for oxidative stress research, enabling precise modulation of ROS and apoptosis pathways in biochemical assays. Its validated purity, solubility profile, and well-characterized mechanism of action support its adoption in advanced research workflows. Ongoing advances in assay design and disease modeling continue to expand the utility of BHA, underscoring the importance of sourcing high-quality material such as APExBIO's C6525 kit. For expanded scenario-driven protocols and troubleshooting, see this practical guide – the present article provides updated purity and workflow integration parameters compared to previous scenario-based overviews.